OraSure Technologies (OSUR) Announces Proposed 8M Share Common Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/25/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Outlook Therapeutics (OTLK) halted, news pending
UPDATE: OraSure Technologies (OSUR) Prices 8M Share Common Offering at $11/Sh
June 3, 2020 5:56 AM EDT(Updated - June 3, 2020 5:56 AM EDT)
OraSure Technologies, Inc. (NASDAQ: OSUR) today announced the pricing of an underwritten offering of 8,000,000 shares of its common stock at a price of $11.00 per share. After the underwriting discount and estimated offering expenses, OraSure expects to receive net proceeds... More
OraSure Technologies (OSUR) Announces Purchase of UrSure, Inc
May 29, 2020 7:00 AM EDTOraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection and stabilization devices, and microbiome laboratory and analytical services, today announced that it has entered into a definitive agreement to acquire privately owned UrSure, Inc. (UrSure) for cash.
Based in Boston, UrSure is developing and commercializing products that measure adherence to HIV medications including pre-exposure prophylaxis or PrEP, the daily medication to prevent HIV. This includes laboratory-based tests that can measure levels of the medication in a patients urine or blood, as well as... More
OraSure Technologies (OSUR) Announces Lelio Marmora to Board
May 29, 2020 6:03 AM EDTOraSure Technologies, Inc. (NASDAQ: OSUR) today announced the appointment of Lelio Marmora as a member of the Companys Board of Directors effective June 1, 2020. Mr. Marmora, the former executive director of Unitaid, will serve as a Class III Director with an initial term expiring at the Companys 2021 Annual Meeting of Stockholders. He will also serve on the Audit Committee and Nominating and Corporate Governance Committee of the Board.
Lelios comprehensive understanding of the international... More
